Literature DB >> 3689331

Organic aciduria in rats made resistant to hypoglycin toxicity by pretreatment with clofibrate.

R K Veitch1, H S Sherratt, K Bartlett.   

Abstract

1. The lethal, hypoglycaemic and hypothermic effects of hypoglycin in fasted rats are prevented if the rats had been fed on a diet containing clofibrate (0.5% w/w). 2. Injection of hypoglycin into fasted rats maintained on a standard diet caused severe prostration, hypothermia and a massive dicarboxylic aciduria [Tanaka (1972) J. Biol. Chem. 247, 7465-7478]. 3. Rats maintained on a diet containing clofibrate appeared normal after injection of hypoglycin, but had a marked dicarboxylic aciduria which was less than that induced in rats on a normal diet. 4. After administration of hypoglycin, butyryl-CoA and decanoyl-CoA, but not palmitoyl-CoA, dehydrogenase activities were strongly inhibited (80-95%) in the livers of animals on a standard diet. 5. Clofibrate feeding decreased the inhibition of these dehydrogenases to about 40-60%. 6. It was concluded that although clofibrate protects against the toxic effects of hypoglycin, some enzyme inhibitions as indicated by dicarboxylic aciduria are only partly prevented.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689331      PMCID: PMC1148344          DOI: 10.1042/bj2460775

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  A novel mechanism for inhibition of beta-oxidation by methylenecyclopropylacetyl-CoA, a metabolite of hypoglycin.

Authors:  H Osmundsen; H S Sherratt
Journal:  FEBS Lett       Date:  1975-07-15       Impact factor: 4.124

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  The specificity of glycine-N-acylase and acylglycine excretion in the organicacidaemias.

Authors:  K Bartlett; D Gompertz
Journal:  Biochem Med       Date:  1974-05

4.  Inhibition of linoleic acid degradation by hypoglycin A.

Authors:  W H Kunau; F Lauterbach
Journal:  FEBS Lett       Date:  1978-10-01       Impact factor: 4.124

5.  Mechanisms of the metabolic disturbances caused by hypoglycin and by pent-4-enoic acid. In vitro studies.

Authors:  D Billington; H Osmundsen; H S Sherratt
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

6.  Increased uptake of fatty acids by the isolated rat liver after raising the fatty acid binding protein concentration with clofibrate.

Authors:  G Renaud; A Foliot; R Infante
Journal:  Biochem Biophys Res Commun       Date:  1978-01-30       Impact factor: 3.575

7.  Hepatic fatty acid oxidation and ketogenesis after clofibrate treatment.

Authors:  G P Mannaerts; J Thomas; L J Debeer; J D McGarry; D W Foster
Journal:  Biochim Biophys Acta       Date:  1978-05-25

8.  Inactivation of general acyl-CoA dehydrogenase from pig kidney by a metabolite of hypoglycin A.

Authors:  A Wenz; C Thorpe; S Ghisla
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

9.  Increase of hepatic mitochondria on administration of ethyl alpha-p-chlorophenoxyisobutyrate to the rat.

Authors:  C K Kurup; H N Aithal; T Ramasarma
Journal:  Biochem J       Date:  1970-03       Impact factor: 3.857

10.  The effects of hypoglycin on glucose metabolism in the rat. A kinetic study in vivo and [U-14C,2-3H]glucose.

Authors:  H Osmundsen; D Billington; J R Taylor; H S Sherratt
Journal:  Biochem J       Date:  1978-02-15       Impact factor: 3.857

View more
  2 in total

1.  Metabolic consequences of methylenecyclopropylglycine poisoning in rats.

Authors:  K Melde; S Jackson; K Bartlett; H S Sherratt; S Ghisla
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  Effects of riboflavin deficiency and clofibrate treatment on the five acyl-CoA dehydrogenases in rat liver mitochondria.

Authors:  K Veitch; J P Draye; F Van Hoof; H S Sherratt
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.